cas 1449598-86-0|| where to buy 2-Chloro-7-fluoro-4H-pyrido[1,2-a]pyrimidin-4-one

Product Name:2-Chloro-7-fluoro-4H-pyrido[1,2-a]pyrimidin-4-one

IUPAC Name:2-chloro-7-fluoro-4H-pyrido[1,2-a]pyrimidin-4-one

Packing Unit	Available Stock	Price($)
CM337294-1g	in stock	ƄźƄ
CM337294-10g	in stock	ưŔŔȎ
CM337294-100g	in stock	ƞǕƞȎ

For R&D use only.

Inquiry Form

Chemical Name

CAS Number

Quantity*

Required Specifications*
(Assay %, Material Grade etc.)

Contact Name*

Contact Email*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1449598-86-0 regularly via the above email.

Additional Notes

Verification code*

refresh

: CAS NO:1449598-86-0; Molecular Formula:C8H4ClFN2O; Melting Point:-; Smiles Code:O=C1C=C(Cl)N=C2N1C=C(F)C=C2; Density:

: Catalog Number:CM337294; Molecular Weight:198.58; Boiling Point:; MDL No:MFCD28659052; Storage:

: Risdiplam; As the first approved small molecule splicing modifier drug, Risdiplam (Evrysdi) is granted approval by the European Commission to expand the EU marketing authorization. This extension now includes infants with a clinical diagnosis of SMA Type 1, Type 2 or Type 3 or with one to four SMN2 copies from birth to below two months. Type 1 spinal muscular atrophy (SMA) is a rare, progressive neuromuscular disease and a leading genetic factor of infant mortality, that is caused by low levels of functional survival of motor neuron (SMN) protein. Risdiplam modifies SMN2 pre-messenger RNA splicing and increases levels of functional SMN protein in both the central nervous system and peripheral organs.